ahlam1399
09-02-2015, 11:10 PM
Regeneron scientists discover key to excess bone growth in rare disease
CHICAGO (Reuters) - Scientists at U.S. biotech**logy company Regeneron Pharmaceuticals researching a rare genetic disease that traps sufferers in a second skeleton have discovered a treatment that shuts down excessive bone growth in mice engineered to develop the illness.
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2.img (http://da.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/ach.img (http://adchoice.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/ach.htm)http://pi.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2t.imghttp://pi2.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49848757/sc/32/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=j-rOqdJJqm0:lFBobNGwup0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=j-rOqdJJqm0:lFBobNGwup0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/j-rOqdJJqm0
CHICAGO (Reuters) - Scientists at U.S. biotech**logy company Regeneron Pharmaceuticals researching a rare genetic disease that traps sufferers in a second skeleton have discovered a treatment that shuts down excessive bone growth in mice engineered to develop the illness.
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/1/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/2/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/3/rc.img (http://rc.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/rc/3/rc.htm)
http://da.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2.img (http://da.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2.htm)
http://adchoice.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/ach.img (http://adchoice.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/ach.htm)http://pi.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2t.imghttp://pi2.feedsportal.com/r/238385091888/u/49/f/654207/c/35217/s/49848757/sc/32/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49848757/sc/32/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=j-rOqdJJqm0:lFBobNGwup0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=j-rOqdJJqm0:lFBobNGwup0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=j-rOqdJJqm0:lFBobNGwup0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/j-rOqdJJqm0